世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界のにきび治療市場。情報:にきびタイプ別(中等度、軽度、中~重度)、治療法別(投薬、治療機器)、薬剤タイプ別(OTC、処方)、投与経路別(外用、経口、注射)、エンドユーザー別(病院・診療所、専門施設)、地域別(アメリカ、ヨーロッパ、アジア太平洋、その他の地域)-2027年までの予測


Global Acne Treatment Market: Information by Acne Type (Moderate, Mild, Moderate to Severe), by Treatment (Medication, Therapeutic Devices), by Drug Type (OTC, Prescription), by Route of Administration (Topical, Oral, Injectable), by End User (Hospitals & Clinics, Specialty Centers) and Region (Americas, Europe, Asia-Pacific, and Rest of the World)Forecast till 2027

Global Acne Treatment Market Forecast till 2027 Acne Treatment Market Overview The acne treatment market is expected to register a CAGR of 5.03% during the forecast period of 2020 to 2027... もっと見る

 

 

出版社 出版年月 価格 ページ数 言語
Market Research Future
マーケットリサーチフューチャー (MRFR)
2021年8月1日 お問い合わせください
ライセンス・価格情報
注文方法はこちら
153 英語

 

サマリー

Global Acne Treatment Market Forecast till 2027

Acne Treatment Market Overview


The acne treatment market is expected to register a CAGR of 5.03% during the forecast period of 2020 to 2027. Acne treatment includes the organization of a few types of prescriptions and balms to ease up the tone of influenced regions. A decent eating regimen is likewise viewed as a vital factor for acne treatment, and this factor has assumed a significant part in the development of the acne treatment market. Also, the rising requirement for further developed drugs for acne treatment has acquired voluminous interests in the acne treatment market.
The global acne treatment market is anticipated to witness a healthy market growth during the review period owing to the highest market value of USD 5,383.05 million in 2019. The growth of the global market is attributed to the rising prevalence of acne vulgaris, growing sedentary lifestyle and unhealthy food habits, High influence of social media, and brand endorsements. However, security issues related to the products being applied for acne treatment and the Failure of pivotal clinical trials for key candidates are expected to restrain the global market growth during the review period.

Market Segmentation
The acne treatment market has been classified into acne type, treatment, drug type, route of administration, and end-user.
Based on acne type, the global market has been classified into moderate acne, mild acne, moderate to severe acne.
Based on Treatment Type the acne treatment market is bifurcated into medication and therapeutic devices.
In terms of Drug Type, the global acne treatment market has been divided into OTC and prescription.
In terms of acne treatment market has been segregated into hospitals & clinics and specialty centers.
Regional Analysis


Geographically, the global acne treatment market, based on region, has been studied across the Americas, Europe, Asia-Pacific, and Middle East & Africa.
Americas drove the acne treatment market in 2019 and is probably going to keep on directing during the survey time frame. This can be credited to the high predominance of acne and skin problems, item dispatches, and mechanical progression around here.

Europe stood firm on the second-biggest foothold in the acne treatment market in 2019 inferable from the natural development systems of organizations and a very much created clinical industry in the area.
The Asia Pacific is expected to register the fastest market growth during the review period followed by the Middle East and Africa.
Major Players
The Key Companies of the global acne treatment market are GlaxoSmithKline plc., Almirall, S.A., Galderma Laboratories, Hoffman La Roche Ltd, Bausch Health Companies Inc, Leo Pharma A/S, Johnson & Johnson Services Inc, Teva Pharmaceutical Industries Ltd, Candela Corporation, and Vyne Therapeutics Inc.

COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.



ページTOPに戻る


目次

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY 18

1.1 OVERVIEW 18

1.1.1 MARKET SYNOPSIS 18

2 MARKET INTRODUCTION 19

2.1 SCOPE OF THE STUDY 19

2.2 RESEARCH OBJECTIVE 19

2.3 LIST OF ASSUMPTIONS & LIMITATIONS 19

3 RESEARCH METHODOLOGY 21

3.1 OVERVIEW 21

3.2 DATA MINING 21

3.3 SECONDARY RESEARCH 22

3.4 PRIMARY RESEARCH 23

3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 23

3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 24

3.5 FORECASTING TECHNIQUES 25

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 25

3.6.1 BOTTOM-UP APPROACH 26

3.6.2 TOP-DOWN APPROACH 27

3.7 DATA TRIANGULATION 28

3.8 VALIDATION 28

4 MARKET DYNAMICS 29

4.1 OVERVIEW 29

4.2 DRIVERS 30

4.2.1 HIGH GLOBAL ACNE PREVALENCE 30

4.2.2 INCREASING SEDENTARY LIFESTYLE AND UNHEALTHY FOOD HABITS 30

4.2.3 HIGH INFLUENCE OF SOCIAL MEDIA AND BRAND ENDORSEMENTS 30

4.2.4 RISE IN THE DISPOSABLE INCOMES OF MIDDLE-CLASS PEOPLE 31

4.3 RESTRAINTS 32

4.3.1 SAFETY ISSUES REGARDING THE PRODUCTS 32

4.3.2 FAILURE OF PIVOTAL CLINICAL TRIALS FOR KEY CANDIDATES 32

4.4 OPPORTUNITIES 33

4.4.1 INCREASING AWARENESS ABOUT CURRENT AND UPCOMING ACNE TREATMENTS 33

4.5 TRENDS 33

4.5.1 ARTIFICIAL INTELLIGENCE ALGORITHM 33

4.5.2 PREFERENCE TOWARDS CLEAN SKINCARE ROUTINE 34

5 MARKET FACTOR ANALYSIS 35

5.1 VALUE CHAIN ANALYSIS 35

5.1.1 R&D AND DESIGNING 36

5.1.2 MANUFACTURING 36

5.1.3 DISTRIBUTION 36

5.1.4 MARKETING & SALES 36

5.2 PORTER’S FIVE FORCES MODEL 36

5.2.1 BARGAINING POWER OF SUPPLIERS 37

5.2.2 BARGAINING POWER OF BUYERS 37

5.2.3 THREAT OF NEW ENTRANTS 38

5.2.4 THREAT OF SUBSTITUTES 38

5.2.5 INTENSITY OF RIVALRY 38

5.3 IMPACT OF COVID-19 38

5.4 PESTEL ANALYSIS 40

6 GLOBAL ACNE TREATMENT MARKET, BY ACNE TYPE 41

6.1 OVERVIEW 41

6.2 MODERATE ACNE 42

6.3 MILD ACNE 43

6.4 MODERATE TO SEVERE ACNE 43

7 GLOBAL ACNE TREATMENT MARKET, BY TREATMENT 44

7.1 OVERVIEW 44

7.2 MEDICATION 45

7.3 THERAPEUTIC DEVICES 46

8 GLOBAL ACNE TREATMENT MARKET, BY DRUG TYPE 48

8.1 OVERVIEW 48

8.2 OTC 49

8.3 PRESCRIPTION 49

9 GLOBAL ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 50

9.1 OVERVIEW 50

9.2 TOPICAL 51

9.3 ORAL 51

9.4 INJECTABLE 52

10 GLOBAL ACNE TREATMENT MARKET, BY END USER 53

10.1 OVERVIEW 53

10.2 HOSPITALS & CLINICS 54

10.3 SPECIALTY CENTERS 54

11 GLOBAL ACNE TREATMENT MARKET, BY REGION 55

11.1 OVERVIEW 55

11.2 AMERICAS 56

11.2.1 NORTH AMERICA 59

11.2.1.1 US 62

11.2.1.2 CANADA 65

11.2.2 LATIN AMERICA 67

11.3 EUROPE 70

11.3.1 WESTERN EUROPE 73

11.3.1.1 GERMANY 76

11.3.1.2 FRANCE 79

11.3.1.3 UK 80

11.3.1.4 ITALY 82

11.3.1.5 SPAIN 84

11.3.1.6 REST OF WESTERN EUROPE 86

11.3.2 EASTERN EUROPE 89

11.4 ASIA-PACIFIC 92

11.4.1 CHINA 95

11.4.2 JAPAN 98

11.4.3 INDIA 100

11.4.4 AUSTRALIA 102

11.4.5 SOUTH KOREA 104

11.4.6 REST OF ASIA-PACIFIC 106

11.5 MIDDLE EAST & AFRICA 109

11.5.1 MIDDLE EAST 112

11.5.2 AFRICA 115

12 COMPETITIVE LANDSCAPE 117

12.1 OVERVIEW 117

12.2 LEADING MARKET PLAYERS 117

12.3 GLOBAL ACNE TREATMENT MARKET SHARE ANALYSIS (2019) 118

12.4 COMPETITIVE BENCHMARKING 119

12.4.1 APPROVAL 120

12.4.2 PRODUCT LAUNCH 120

12.4.3 EXPANSION & ACQUISITION 121

12.4.4 AGREEMENT 121

12.5 LIST OF COMPANIES AND THEIR PRODUCTS FOR ACNE TREATMENT 122

13 COMPANY PROFILES 126

13.1 GLAXOSMITHKLINE PLC 126

13.1.1 COMPANY OVERVIEW 126

13.1.2 FINANCIAL OVERVIEW 127

13.1.3 PRODUCTS/SERVICES OFFERED 127

13.1.4 KEY DEVELOPMENTS 128

13.1.5 SWOT ANALYSIS 128

13.1.6 KEY STRATEGIES 128

13.2 ALMIRALL, S.A. 129

13.2.1 COMPANY OVERVIEW 129

13.2.2 FINANCIAL OVERVIEW 129

13.2.3 PRODUCTS/SERVICES OFFERED 130

13.2.4 ALMIRALL, S.A: KEY DEVELOPMENTS 130

13.2.5 SWOT ANALYSIS 131

13.2.6 KEY STRATEGIES 131

13.3 GALDERMA LABORATORIES, L.P. 132

13.3.1 COMPANY OVERVIEW 132

13.3.2 FINANCIAL OVERVIEW 132

13.3.3 PRODUCTS/SERVICES OFFERED 132

13.3.4 KEY DEVELOPMENTS 133

13.3.5 SWOT ANALYSIS 133

13.3.6 KEY STRATEGIES 133

13.4 F. HOFFMAN LA ROCHE LTD 134

13.4.1 COMPANY OVERVIEW 134

13.4.2 FINANCIAL OVERVIEW 135

13.4.3 PRODUCTS/SERVICES OFFERED 135

13.4.4 KEY DEVELOPMENTS 135

13.4.5 SWOT ANALYSIS 136

13.4.6 KEY STRATEGIES 136

13.5 BAUSCH HEALTH COMPANIES INC. 137

13.5.1 COMPANY OVERVIEW 137

13.5.2 FINANCIAL OVERVIEW 137

13.5.3 PRODUCTS/SERVICES OFFERED 138

13.5.4 KEY DEVELOPMENTS 138

13.5.5 SWOT ANALYSIS 139

13.5.6 KEY STRATEGIES 139

13.6 LEO PHARMA A/S 140

13.6.1 COMPANY OVERVIEW 140

13.6.2 FINANCIAL OVERVIEW 140

13.6.3 PRODUCTS/SERVICES OFFERED 141

13.6.4 KEY DEVELOPMENTS 141

13.6.5 SWOT ANALYSIS 141

13.6.6 KEY STRATEGIES 142

13.7 JOHNSON & JOHNSON SERVICES INC. 143

13.7.1 COMPANY OVERVIEW 143

13.7.2 FINANCIAL OVERVIEW 143

13.7.3 PRODUCTS/SERVICES OFFERED 144

13.7.4 KEY DEVELOPMENTS 144

13.7.5 SWOT ANALYSIS 144

13.7.6 KEY STRATEGIES 145

13.8 TEVA PHARMACEUTICAL INDUSTRIES LTD 146

13.8.1 COMPANY OVERVIEW 146

13.8.2 FINANCIAL OVERVIEW 146

13.8.3 PRODUCTS/SERVICES OFFERED 147

13.8.4 KEY DEVELOPMENTS 147

13.8.5 SWOT ANALYSIS 147

13.8.6 KEY STRATEGIES 148

13.9 CANDELA CORPORATION 149

13.9.1 COMPANY OVERVIEW 149

13.9.2 FINANCIAL OVERVIEW 149

13.9.3 PRODUCTS/SERVICES OFFERED 149

13.9.4 KEY DEVELOPMENTS 149

13.9.5 SWOT ANALYSIS 150

13.9.6 KEY STRATEGIES 150

13.10 VYNE THERAPEUTICS INC. 151

13.10.1 COMPANY OVERVIEW 151

13.10.2 FINANCIAL OVERVIEW 151

13.10.3 PRODUCTS/SERVICES OFFERED 151

13.10.4 KEY DEVELOPMENTS 152

13.10.5 SWOT ANALYSIS 152

13.10.6 KEY STRATEGIES 152



14 APPENDIX 153

14.1 REFERENCES 153

14.2 RELATED REPORTS 153

 

ページTOPに戻る


 

Summary

Global Acne Treatment Market Forecast till 2027

Acne Treatment Market Overview


The acne treatment market is expected to register a CAGR of 5.03% during the forecast period of 2020 to 2027. Acne treatment includes the organization of a few types of prescriptions and balms to ease up the tone of influenced regions. A decent eating regimen is likewise viewed as a vital factor for acne treatment, and this factor has assumed a significant part in the development of the acne treatment market. Also, the rising requirement for further developed drugs for acne treatment has acquired voluminous interests in the acne treatment market.
The global acne treatment market is anticipated to witness a healthy market growth during the review period owing to the highest market value of USD 5,383.05 million in 2019. The growth of the global market is attributed to the rising prevalence of acne vulgaris, growing sedentary lifestyle and unhealthy food habits, High influence of social media, and brand endorsements. However, security issues related to the products being applied for acne treatment and the Failure of pivotal clinical trials for key candidates are expected to restrain the global market growth during the review period.

Market Segmentation
The acne treatment market has been classified into acne type, treatment, drug type, route of administration, and end-user.
Based on acne type, the global market has been classified into moderate acne, mild acne, moderate to severe acne.
Based on Treatment Type the acne treatment market is bifurcated into medication and therapeutic devices.
In terms of Drug Type, the global acne treatment market has been divided into OTC and prescription.
In terms of acne treatment market has been segregated into hospitals & clinics and specialty centers.
Regional Analysis


Geographically, the global acne treatment market, based on region, has been studied across the Americas, Europe, Asia-Pacific, and Middle East & Africa.
Americas drove the acne treatment market in 2019 and is probably going to keep on directing during the survey time frame. This can be credited to the high predominance of acne and skin problems, item dispatches, and mechanical progression around here.

Europe stood firm on the second-biggest foothold in the acne treatment market in 2019 inferable from the natural development systems of organizations and a very much created clinical industry in the area.
The Asia Pacific is expected to register the fastest market growth during the review period followed by the Middle East and Africa.
Major Players
The Key Companies of the global acne treatment market are GlaxoSmithKline plc., Almirall, S.A., Galderma Laboratories, Hoffman La Roche Ltd, Bausch Health Companies Inc, Leo Pharma A/S, Johnson & Johnson Services Inc, Teva Pharmaceutical Industries Ltd, Candela Corporation, and Vyne Therapeutics Inc.

COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.



ページTOPに戻る


Table of Contents

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY 18

1.1 OVERVIEW 18

1.1.1 MARKET SYNOPSIS 18

2 MARKET INTRODUCTION 19

2.1 SCOPE OF THE STUDY 19

2.2 RESEARCH OBJECTIVE 19

2.3 LIST OF ASSUMPTIONS & LIMITATIONS 19

3 RESEARCH METHODOLOGY 21

3.1 OVERVIEW 21

3.2 DATA MINING 21

3.3 SECONDARY RESEARCH 22

3.4 PRIMARY RESEARCH 23

3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 23

3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 24

3.5 FORECASTING TECHNIQUES 25

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 25

3.6.1 BOTTOM-UP APPROACH 26

3.6.2 TOP-DOWN APPROACH 27

3.7 DATA TRIANGULATION 28

3.8 VALIDATION 28

4 MARKET DYNAMICS 29

4.1 OVERVIEW 29

4.2 DRIVERS 30

4.2.1 HIGH GLOBAL ACNE PREVALENCE 30

4.2.2 INCREASING SEDENTARY LIFESTYLE AND UNHEALTHY FOOD HABITS 30

4.2.3 HIGH INFLUENCE OF SOCIAL MEDIA AND BRAND ENDORSEMENTS 30

4.2.4 RISE IN THE DISPOSABLE INCOMES OF MIDDLE-CLASS PEOPLE 31

4.3 RESTRAINTS 32

4.3.1 SAFETY ISSUES REGARDING THE PRODUCTS 32

4.3.2 FAILURE OF PIVOTAL CLINICAL TRIALS FOR KEY CANDIDATES 32

4.4 OPPORTUNITIES 33

4.4.1 INCREASING AWARENESS ABOUT CURRENT AND UPCOMING ACNE TREATMENTS 33

4.5 TRENDS 33

4.5.1 ARTIFICIAL INTELLIGENCE ALGORITHM 33

4.5.2 PREFERENCE TOWARDS CLEAN SKINCARE ROUTINE 34

5 MARKET FACTOR ANALYSIS 35

5.1 VALUE CHAIN ANALYSIS 35

5.1.1 R&D AND DESIGNING 36

5.1.2 MANUFACTURING 36

5.1.3 DISTRIBUTION 36

5.1.4 MARKETING & SALES 36

5.2 PORTER’S FIVE FORCES MODEL 36

5.2.1 BARGAINING POWER OF SUPPLIERS 37

5.2.2 BARGAINING POWER OF BUYERS 37

5.2.3 THREAT OF NEW ENTRANTS 38

5.2.4 THREAT OF SUBSTITUTES 38

5.2.5 INTENSITY OF RIVALRY 38

5.3 IMPACT OF COVID-19 38

5.4 PESTEL ANALYSIS 40

6 GLOBAL ACNE TREATMENT MARKET, BY ACNE TYPE 41

6.1 OVERVIEW 41

6.2 MODERATE ACNE 42

6.3 MILD ACNE 43

6.4 MODERATE TO SEVERE ACNE 43

7 GLOBAL ACNE TREATMENT MARKET, BY TREATMENT 44

7.1 OVERVIEW 44

7.2 MEDICATION 45

7.3 THERAPEUTIC DEVICES 46

8 GLOBAL ACNE TREATMENT MARKET, BY DRUG TYPE 48

8.1 OVERVIEW 48

8.2 OTC 49

8.3 PRESCRIPTION 49

9 GLOBAL ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 50

9.1 OVERVIEW 50

9.2 TOPICAL 51

9.3 ORAL 51

9.4 INJECTABLE 52

10 GLOBAL ACNE TREATMENT MARKET, BY END USER 53

10.1 OVERVIEW 53

10.2 HOSPITALS & CLINICS 54

10.3 SPECIALTY CENTERS 54

11 GLOBAL ACNE TREATMENT MARKET, BY REGION 55

11.1 OVERVIEW 55

11.2 AMERICAS 56

11.2.1 NORTH AMERICA 59

11.2.1.1 US 62

11.2.1.2 CANADA 65

11.2.2 LATIN AMERICA 67

11.3 EUROPE 70

11.3.1 WESTERN EUROPE 73

11.3.1.1 GERMANY 76

11.3.1.2 FRANCE 79

11.3.1.3 UK 80

11.3.1.4 ITALY 82

11.3.1.5 SPAIN 84

11.3.1.6 REST OF WESTERN EUROPE 86

11.3.2 EASTERN EUROPE 89

11.4 ASIA-PACIFIC 92

11.4.1 CHINA 95

11.4.2 JAPAN 98

11.4.3 INDIA 100

11.4.4 AUSTRALIA 102

11.4.5 SOUTH KOREA 104

11.4.6 REST OF ASIA-PACIFIC 106

11.5 MIDDLE EAST & AFRICA 109

11.5.1 MIDDLE EAST 112

11.5.2 AFRICA 115

12 COMPETITIVE LANDSCAPE 117

12.1 OVERVIEW 117

12.2 LEADING MARKET PLAYERS 117

12.3 GLOBAL ACNE TREATMENT MARKET SHARE ANALYSIS (2019) 118

12.4 COMPETITIVE BENCHMARKING 119

12.4.1 APPROVAL 120

12.4.2 PRODUCT LAUNCH 120

12.4.3 EXPANSION & ACQUISITION 121

12.4.4 AGREEMENT 121

12.5 LIST OF COMPANIES AND THEIR PRODUCTS FOR ACNE TREATMENT 122

13 COMPANY PROFILES 126

13.1 GLAXOSMITHKLINE PLC 126

13.1.1 COMPANY OVERVIEW 126

13.1.2 FINANCIAL OVERVIEW 127

13.1.3 PRODUCTS/SERVICES OFFERED 127

13.1.4 KEY DEVELOPMENTS 128

13.1.5 SWOT ANALYSIS 128

13.1.6 KEY STRATEGIES 128

13.2 ALMIRALL, S.A. 129

13.2.1 COMPANY OVERVIEW 129

13.2.2 FINANCIAL OVERVIEW 129

13.2.3 PRODUCTS/SERVICES OFFERED 130

13.2.4 ALMIRALL, S.A: KEY DEVELOPMENTS 130

13.2.5 SWOT ANALYSIS 131

13.2.6 KEY STRATEGIES 131

13.3 GALDERMA LABORATORIES, L.P. 132

13.3.1 COMPANY OVERVIEW 132

13.3.2 FINANCIAL OVERVIEW 132

13.3.3 PRODUCTS/SERVICES OFFERED 132

13.3.4 KEY DEVELOPMENTS 133

13.3.5 SWOT ANALYSIS 133

13.3.6 KEY STRATEGIES 133

13.4 F. HOFFMAN LA ROCHE LTD 134

13.4.1 COMPANY OVERVIEW 134

13.4.2 FINANCIAL OVERVIEW 135

13.4.3 PRODUCTS/SERVICES OFFERED 135

13.4.4 KEY DEVELOPMENTS 135

13.4.5 SWOT ANALYSIS 136

13.4.6 KEY STRATEGIES 136

13.5 BAUSCH HEALTH COMPANIES INC. 137

13.5.1 COMPANY OVERVIEW 137

13.5.2 FINANCIAL OVERVIEW 137

13.5.3 PRODUCTS/SERVICES OFFERED 138

13.5.4 KEY DEVELOPMENTS 138

13.5.5 SWOT ANALYSIS 139

13.5.6 KEY STRATEGIES 139

13.6 LEO PHARMA A/S 140

13.6.1 COMPANY OVERVIEW 140

13.6.2 FINANCIAL OVERVIEW 140

13.6.3 PRODUCTS/SERVICES OFFERED 141

13.6.4 KEY DEVELOPMENTS 141

13.6.5 SWOT ANALYSIS 141

13.6.6 KEY STRATEGIES 142

13.7 JOHNSON & JOHNSON SERVICES INC. 143

13.7.1 COMPANY OVERVIEW 143

13.7.2 FINANCIAL OVERVIEW 143

13.7.3 PRODUCTS/SERVICES OFFERED 144

13.7.4 KEY DEVELOPMENTS 144

13.7.5 SWOT ANALYSIS 144

13.7.6 KEY STRATEGIES 145

13.8 TEVA PHARMACEUTICAL INDUSTRIES LTD 146

13.8.1 COMPANY OVERVIEW 146

13.8.2 FINANCIAL OVERVIEW 146

13.8.3 PRODUCTS/SERVICES OFFERED 147

13.8.4 KEY DEVELOPMENTS 147

13.8.5 SWOT ANALYSIS 147

13.8.6 KEY STRATEGIES 148

13.9 CANDELA CORPORATION 149

13.9.1 COMPANY OVERVIEW 149

13.9.2 FINANCIAL OVERVIEW 149

13.9.3 PRODUCTS/SERVICES OFFERED 149

13.9.4 KEY DEVELOPMENTS 149

13.9.5 SWOT ANALYSIS 150

13.9.6 KEY STRATEGIES 150

13.10 VYNE THERAPEUTICS INC. 151

13.10.1 COMPANY OVERVIEW 151

13.10.2 FINANCIAL OVERVIEW 151

13.10.3 PRODUCTS/SERVICES OFFERED 151

13.10.4 KEY DEVELOPMENTS 152

13.10.5 SWOT ANALYSIS 152

13.10.6 KEY STRATEGIES 152



14 APPENDIX 153

14.1 REFERENCES 153

14.2 RELATED REPORTS 153

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

Market Research Future社のその他分野での最新刊レポート

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


Market Research Future社はどのような調査会社ですか?


マーケットリサーチフューチャー(Market Research Future)は世界市場を幅広く調査し、主要分野、地域、国レベルの調査レポートを出版しています。   下記分野については、分野毎に専... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/20 10:26

155.91 円

165.77 円

200.60 円

ページTOPに戻る